Clinical Trials

89 enrolled

Uterine Cervical Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

120 enrolled

Uterine Cervical Neoplasms

NCT07435623 2026-03-02

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

300 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03256916 2026-02-24

NELCER

Phase 3 Completed

348 enrolled

Uterine Cervical Neoplasms

NCT03005743 2026-02-23

COMBAT-Cx

1,050 enrolled

Uterine Cervical Neoplasms

NCT05102240 2026-02-20

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

1,800 enrolled

Uterine Cervical Neoplasms

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

20 enrolled

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT03997110 2026-02-17

RAPPAL

230 enrolled

Uterine Cervical Neoplasms

NCT07400809 2026-02-17

Retro-COSMOS

350 enrolled

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence

NCT01279135 2026-02-06

PARCER

Phase 3 Completed

300 enrolled

Uterine Cervical Neoplasms

NCT06804135 2026-02-04

STIRR

110 enrolled

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT07164534 2026-02-04

CHOC-LATE

316 enrolled

Uterine Cervical Neoplasms

NCT07290972 2026-02-04

NCG-Compliance

618 enrolled

Phase NA Not yet recruiting

Uterine Cervical Neoplasms, Neoplasms, Patient Compliance, Recurrence

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

74 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases, Vaginal Neoplasms, Endometrial Neoplasms

NCT07050745 2026-01-12

DADA-LINK

1,980 enrolled

Uterine Cervical Neoplasms

NCT07181278 2025-12-02

OptiTri_MT

1,180 enrolled

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms

NCT07245381 2025-11-24

Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation

65 enrolled

Uterine Cervical Neoplasms

NCT06560697 2025-10-07

SABRVICAL

84 enrolled

Phase NA Enrolling by invitation

Uterine Cervical Neoplasms

NCT06942286 2025-09-17

Primary HPV Self-Collection in Indonesia

8,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07177170 2025-09-16

OptiTri_GC

1,422 enrolled

Phase EARLY_PHASE1 Recruiting

Uterine Cervical Neoplasms

NCT07106814 2025-09-15

Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

36 enrolled

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Liver Neoplasms

NCT07055399 2025-09-11

NICE-CC

43 enrolled

Uterine Cervical Neoplasms

NCT07113236 2025-08-21

Effectiveness of Interventions for Improving HPV Vaccination Cover

320 enrolled

Uterine Cervical Neoplasms

NCT06967740 2025-07-31

Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs

200 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07077980 2025-07-22

Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines

50 enrolled

GastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

20 enrolled

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT01837693 2025-06-26

NTCC2

GynecologicOther neoplasm

41,127 enrolled

Uterine Cervical Neoplasms, Hypersensitivity, Neoplasms, Precancerous Conditions

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

18 enrolled

Phase NA Enrolling by invitation

Uterine Cervical Neoplasms, Renal Insufficiency

NCT04165460 2025-05-28

Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients

92 enrolled

Treatment Adherence and Compliance, Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Orgasm

NCT03994055 2025-05-25

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

136 enrolled

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Neoplasms, Radiation Injuries

NCT06562595 2025-05-20

What is the Optimal Training Model for Cervical Awareness?

400 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06528184 2025-02-10

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

650 enrolled

Phase 1 Not yet recruiting

Uterine Cervical Neoplasms

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

90 enrolled

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT05855941 2024-12-16

PRODIGYN

120 enrolled

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06140589 2024-09-19

Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer

200 enrolled

BreastGynecologicHead & Neck

Uterine Cervical Neoplasms

NCT05099978 2024-09-04

A-TRAIN

Unknown

506 enrolled

Nasopharyngeal Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05662683 2024-07-09

Pap-Smear

132 enrolled

Anxiety Disorders, Uterine Cervical Neoplasms, Pain, Smear Layer

NCT06456112 2024-07-01

Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

83 enrolled

Uterine Cervical Neoplasms

NCT06455072 2024-06-12

Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

37 enrolled

Uterine Cervical Neoplasms

NCT06253169 2024-04-23

ASTRA

2,000 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05910177 2024-03-06

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin

30 enrolled

Carcinoma, Uterine Cervical Neoplasms

NCT06197126 2024-01-09

MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy

200 enrolled

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT06149767 2023-11-29

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

26 enrolled

Uterine Cervical Neoplasms

NCT04903561 2023-11-24

BELGSSAR

Phase NA Unknown

1,200 enrolled

Uterine Cervical Neoplasms

NCT03750539 2023-11-14

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

Phase NA Unknown

100 enrolled

Uterine Cervical Neoplasms

NCT04067882 2023-11-14

Validation of the Genetic Signature 354849 as a Prognostic Method

Unknown

189 enrolled

Uterine Cervical Neoplasms

NCT04070976 2023-11-14

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer

Phase NA Unknown

82 enrolled

Uterine Cervical Neoplasms

NCT06101966 2023-10-26

A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy

500 enrolled